These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 21224393

  • 1. The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells.
    Fernández-Messina L, Ashiru O, Agüera-González S, Reyburn HT, Valés-Gómez M.
    J Cell Sci; 2011 Feb 01; 124(Pt 3):321-7. PubMed ID: 21224393
    [Abstract] [Full Text] [Related]

  • 2. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.
    Rölle A, Mousavi-Jazi M, Eriksson M, Odeberg J, Söderberg-Nauclér C, Cosman D, Kärre K, Cerboni C.
    J Immunol; 2003 Jul 15; 171(2):902-8. PubMed ID: 12847260
    [Abstract] [Full Text] [Related]

  • 3. RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity.
    Cao W, Xi X, Hao Z, Li W, Kong Y, Cui L, Ma C, Ba D, He W.
    J Biol Chem; 2007 Jun 29; 282(26):18922-8. PubMed ID: 17470428
    [Abstract] [Full Text] [Related]

  • 4. Natural killer cell-mediated shedding of ULBP2.
    Wang R, Sun PD.
    PLoS One; 2014 Jun 29; 9(3):e91133. PubMed ID: 24614922
    [Abstract] [Full Text] [Related]

  • 5. Human Natural Killer cell expression of ULBP2 is associated with a mature functional phenotype.
    Brennan K, McSharry BP, Keating S, Petrasca A, O'Reilly VP, Keane J, Doherty DG, Gardiner CM.
    Hum Immunol; 2016 Oct 29; 77(10):876-885. PubMed ID: 27349945
    [Abstract] [Full Text] [Related]

  • 6. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.
    Textor S, Fiegler N, Arnold A, Porgador A, Hofmann TG, Cerwenka A.
    Cancer Res; 2011 Sep 15; 71(18):5998-6009. PubMed ID: 21764762
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differential NKG2D binding to highly related human NKG2D ligands ULBP2 and RAET1G is determined by a single amino acid in the alpha2 domain.
    Wittenbrink M, Spreu J, Steinle A.
    Eur J Immunol; 2009 Jun 15; 39(6):1642-51. PubMed ID: 19424970
    [Abstract] [Full Text] [Related]

  • 10. Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications.
    Jimenez-Perez MI, Jave-Suarez LF, Ortiz-Lazareno PC, Bravo-Cuellar A, Gonzalez-Ramella O, Aguilar-Lemarroy A, Hernandez-Flores G, Pereira-Suarez AL, Daneri-Navarro A, del Toro-Arreola S.
    BMC Immunol; 2012 Feb 08; 13():7. PubMed ID: 22316211
    [Abstract] [Full Text] [Related]

  • 11. Cutting edge: NKG2D-dependent cytotoxicity is controlled by ligand distribution in the target cell membrane.
    Martinez E, Brzostowski JA, Long EO, Gross CC.
    J Immunol; 2011 May 15; 186(10):5538-42. PubMed ID: 21464092
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A conserved WW domain-like motif regulates invariant chain-dependent cell-surface transport of the NKG2D ligand ULBP2.
    Uhlenbrock F, van Andel E, Andresen L, Skov S.
    Mol Immunol; 2015 Aug 15; 66(2):418-27. PubMed ID: 25983110
    [Abstract] [Full Text] [Related]

  • 14. Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ.
    Galitska G, Coscia A, Forni D, Steinbrueck L, De Meo S, Biolatti M, De Andrea M, Cagliani R, Leone A, Bertino E, Schulz T, Santoni A, Landolfo S, Sironi M, Cerboni C, Dell'Oste V.
    Front Immunol; 2021 Aug 15; 12():532484. PubMed ID: 33897679
    [Abstract] [Full Text] [Related]

  • 15. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D.
    Eleme K, Taner SB, Onfelt B, Collinson LM, McCann FE, Chalupny NJ, Cosman D, Hopkins C, Magee AI, Davis DM.
    J Exp Med; 2004 Apr 05; 199(7):1005-10. PubMed ID: 15051759
    [Abstract] [Full Text] [Related]

  • 16. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
    Matusali G, Tchidjou HK, Pontrelli G, Bernardi S, D'Ettorre G, Vullo V, Buonomini AR, Andreoni M, Santoni A, Cerboni C, Doria M.
    FASEB J; 2013 Jun 05; 27(6):2440-50. PubMed ID: 23395909
    [Abstract] [Full Text] [Related]

  • 17. Structure of the HCMV UL16-MICB complex elucidates select binding of a viral immunoevasin to diverse NKG2D ligands.
    Müller S, Zocher G, Steinle A, Stehle T.
    PLoS Pathog; 2010 Jan 15; 6(1):e1000723. PubMed ID: 20090832
    [Abstract] [Full Text] [Related]

  • 18. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells.
    Sutherland CL, Chalupny NJ, Schooley K, VandenBos T, Kubin M, Cosman D.
    J Immunol; 2002 Jan 15; 168(2):671-9. PubMed ID: 11777960
    [Abstract] [Full Text] [Related]

  • 19. Clinical Impact of Natural Killer Group 2D Receptor Expression and That of Its Ligand in Ovarian Carcinomas: A Retrospective Study.
    Lee GH, An HJ, Kim TH, Kim G, Park KS, Park H, Lee TH, Kwon AY.
    Yonsei Med J; 2021 Apr 15; 62(4):288-297. PubMed ID: 33779082
    [Abstract] [Full Text] [Related]

  • 20. Transfer of the human NKG2D ligands UL16 binding proteins (ULBP) 1-3 is related to lytic granule release and leads to ligand retransfer and killing of ULBP-recipient natural killer cells.
    López-Cobo S, Romera-Cárdenas G, García-Cuesta EM, Reyburn HT, Valés-Gómez M.
    Immunology; 2015 Sep 15; 146(1):70-80. PubMed ID: 25980678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.